Search Results - Sharma-Haase, Kamni

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Effectiveness, safety and feasibility of extended‐release naltrexone for opioid dependence: a 9‐month follow‐up to a 3‐month randomized trial

    Effectiveness, safety and feasibility of extended‐release naltrexone for opioid dependence: a 9‐month follow‐up to a 3‐month randomized trial by Solli, Kristin Klemmetsby, Latif, Zill‐e‐Huma, Opheim, Arild, Krajci, Peter, Sharma‐Haase, Kamni, Benth, Jūratė Šaltytė, Tanum, Lars, Kunoe, Nikolaj

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone A Randomized Clinical Trial and Follow-up Study

    Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone A Randomized Clinical Trial and Follow-up S... by Latif, Zill-E-Huma, Saltyte Benth, Jurate, Solli, Kristin Klemmetsby, Opheim, Arild, Kunøe, Nikolaj, Krajci, Peter, Haase, Kamni Sharma, Tanum, Lars Håkon Reiestad

    Request full text
    Article
    Save to List
    Saved in:
  3. 3
    No increased pain among opioid‐dependent individuals treated with extended‐release naltrexone or buprenorphine‐naloxone: A 3‐month randomized study and 9‐month open‐treatment follow‐up study

    No increased pain among opioid‐dependent individuals treated with extended‐release naltrexone or buprenorphine‐naloxone: A 3‐month randomized study and 9‐month open‐treatment follo... by Latif, Zill‐e‐Huma, Solli, Kristin K., Opheim, Arild, Kunoe, Nikolaj, Benth, Jūratė Š., Krajci, Peter, Sharma‐Haase, Kamni, Tanum, Lars

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial

    Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial by Solli, Kristin Klemmetsby, Kunoe, Nikolaj, Latif, Zill-E-Huma, Sharma-Haase, Kamni, Opheim, Arild, Krajci, Peter, Gaulen, Zhanna, Benth, Jūratė Šaltytė, Tanum, Lars

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Interest in Extended Release Naltrexone among Opioid Users

    Interest in Extended Release Naltrexone among Opioid Users by Haase, Kamni Sharma, Kunøe, Nikolaj, Opheim, Arild, Gaulen, Zhanna, Njå, Anne-Lill Mjølhus, Latif, Zill-E-Huma, Solli, Kristin Klemmetsby, Tanum, Lars

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Optimal prevention of relapse among opioid users: A 12-week randomized controlled trial of extended-release naltrexone injections versus daily buprenorphine-naloxone

    Optimal prevention of relapse among opioid users: A 12-week randomized controlled trial of extended-release naltrexone injections versus daily buprenorphine-naloxone by Tanum, Lars Hakon, Opheim, Arild, Solli, Kristin, Sharma-Haase, Kamni, Latif, Zill-e-Huma, Kunoe, Nikolaj

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)

    Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX) by Kunøe, Nikolaj, Opheim, Arild, Solli, Kristin Klemmetsby, Gaulen, Zhanna, Sharma-Haase, Kamni, Latif, Zill-E-Huma, Tanum, Lars

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: Extension of a randomized clinical trial

    Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: Extension of a randomized clinical trial by Solli, Kristin Klemmetsby, Kunøe, Nikolaj, Latif, Zill-E-Huma, Haase, Kamni Sharma, Opheim, Arild, Krajci, Peter, Gaulen, Zhanna, Saltyte Benth, Jurate, Tanum, Lars Håkon Reiestad

    Request full text
    Article
    Save to List
    Saved in:
  9. 9
    Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: Extension of a randomized clinical trial

    Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: Extension of a randomized clinical trial by Solli, Kristin Klemmetsby, Kunøe, Nikolaj, Latif, Zill-E-Huma, Haase, Kamni Sharma, Opheim, Arild, Krajci, Peter, Gaulen, Zhanna, Saltyte Benth, Jurate, Tanum, Lars Håkon Reiestad

    Request full text
    Article
    Save to List
    Saved in:

Search Tools: